Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare reported strong consolidated Q1 FY26 results with revenue from operations of ₹2,02,757 lakhs, up ~31% YoY from ₹1,54,295 lakhs. Profit after tax rose ~30% to ₹30,797 lakhs (vs ₹23,627 lakhs), and EPS grew to ₹3.17 from ₹2.43. The auditor (S.R. Batliboi & Co. LLP) issued an unmodified review report. The board also approved a built-to-suit lease with Goyal Agrim Infra Realty LLP for a ~130-bed hospital in Dehradun, expected by 2028, with an estimated investment of ₹170-200 crore funded by internal accruals. Network capacity utilization was over 76% in Q1, with the existing Dehradun hospital at >80% occupancy. The company also noted progress on the amalgamation of subsidiaries CRL and JHL and a land acquisition in Ghaziabad for ~150 additional beds.
Strong double-digit revenue and profit growth signals robust operational momentum and supports investor confidence. The Dehradun expansion addresses high occupancy and adds future revenue, while internal accrual funding keeps the balance sheet healthy. Overall positive for shareholders.